Champion™ pET SUMO Expression System
Product Image
Invitrogen™

Champion™ pET SUMO Expression System

El sistema de expresión Champion™ pET SUMO produce los niveles más altos de proteína soluble en E. coli. Utiliza laMás información
Have Questions?
Número de catálogoCantidad
K3000120 reacciones
Número de catálogo K30001
Precio (CLP)
1.595.552
Each
Añadir al carro de la compra
Cantidad:
20 reacciones
Precio (CLP)
1.595.552
Each
Añadir al carro de la compra
El sistema de expresión Champion™ pET SUMO produce los niveles más altos de proteína soluble en E. coli. Utiliza la fusión del modificador relacionado con ubiquitina pequeña (SUMO), que pertenece a una familia creciente de proteínas relacionadas con la ubiquitina, para mejorar la solubilidad de las proteínas de fusión expresadas. A diferencia de la ubiquitina, el SUMO participa en la estabilización y localización de proteínas in vivo. Después de la expresión, la fracción de SUMO de 11 kd se puede escindir mediante proteasa de SUMO (ULP-1) altamente específica y activa en el terminal carboxilo, lo que produce una proteína nativa*. El sistema de expresión de proteínas y péptidos Champion™ pET SUMO ofrece:

• Solubilidad muy mejorada con fusión de SUMO N-terminal. Escisión altamente eficaz: produce proteína nativa de interés con (ULP-1) proteasa de SUMO*. Escisión altamente específica: elimina la posibilidad de que su proteína de interés se digiera internamente, independientemente de su secuencia de aminoácidos. Aumento significativo de la estabilidad con la fusión de SUMO: puede usarse para el promotor T7lac de producción de péptidos pequeños para una expresión de proteínas de alto nivel. Etiqueta 6xHis N-terminal para la detección y purificación de proteínas
Para uso exclusivo en investigación. No apto para uso en procedimientos diagnósticos.
Especificaciones
Resistencia bacteriana a los antibióticosKanamicina (KanR)
Cepa bacteriana o de levaduraBL21(DE3)
HendiduraSUMO
Sistema constitutivo o inducibleInducible
Mecanismo de expresiónExpresión basada en células
Sistema de expresiónE. coli
Agente inductorIPTG
Tipo de productoSistema de expresión
Cantidad20 reacciones
Agente de selección (eucariótico)Ninguno
VectorpET
Método de clonaciónTOPO
Línea de productosLiderar, TA Cloning
PromotorT7, lacO
Etiqueta de proteínaEtiqueta His (6x), Etiqueta SUMO
Unit SizeEach
Contenido y almacenamiento
El sistema de expresión de SUMO pET CHAMPION™ se proporciona como un sistema completo. La caja Champion™ pET SUMO TA Cloning™ contiene el vector Champion™ pET SUMO linealizado, agua estéril, dNTPs, tampón 10X para PCR, plantilla de control y cebadores, ADN ligasa T4, tampón de ligación 10X, cebadores para secuenciación o cribado por PCR y un control de expresión. Conservar a -20°C. La caja de proteasa de SUMO contiene tampones y proteasa de SUMO. Conservar a -80°C. La caja One Shot™ TOP10 contiene veintiuna alícuotas de 50μl de E. coli químicamente competente, medio S.O.C. y un plásmido de control. Conservar a -80°C. La caja One Shot¤ BL21(DE3) contiene veintiuna alícuotas de 50 μl de E. coli químicamente competente, medio S.O.C. y un plásmido de control. Conservar a -80°C.

Preguntas frecuentes

My gene of interest is toxic to bacterial cells. Are there any precautions you can suggest?

Several precautions may be taken to prevent problems resulting from basal level expression of a toxic gene of interest. These methods all assume that the T7-based or Champion-based expression plasmid has been correctly designed and created.

- Propagate and maintain your expression plasmid in a strain that does not contain T7 RNA polymerase (i.e., DH5α).
- If using BL21 (DE3) cells, try growing cells at room temperature rather than 37 degrees C for 24-48 hr.
- Perform a fresh transformation using a tightly regulated E. coli strain, such as BL21-AI cells.
- After following the transformation protocol, plate the transformation reaction on LB plates containing 100 µg/mL ampicillin and 0.1% glucose. The presence of glucose represses basal expression of T7 RNA polymerase.
- Following transformation of BL21-AI cells, pick 3 or 4 transformants and inoculate directly into fresh LB medium containing 100 µg/mL ampicillin or 50 µg/mL carbenicillin (and 0.1% glucose, if desired). When the culture reaches an OD600 of 0.4, induce expression of the recombinant protein by adding L-arabinose to a final concentration of 0.2%.
- When performing expression experiments, supplement the growth medium with 0.1% glucose in addition to 0.2% arabinose.
- Try a regulated bacterial expression system such as our pBAD system.

Find additional tips, troubleshooting help, and resources within our Protein Expression Support Center.

I'm trying to express my protein using a bacterial expression system. How do I know if I'm seeing degradation of my protein or if what I’m seeing is codon usage bias?

Typically, if you see 1-2 dominant bands, translation stopped prematurely due to codon usage bias. With degradation, you usually see a ladder of bands. With degradation, you can try using a protease inhibitor and add it to the lysis buffer to help prevent degradation. If degradation is the issue, a time point experiment can be done to determine the best time to harvest the cells.

Find additional tips, troubleshooting help, and resources within our Protein Expression Support Center.

I'm trying to express my protein using a bacterial expression system and am getting inclusion bodies. What should I do?

If you are having a solubility issue, try to decrease the temperature or decrease the amount of IPTG used for induction. You can also try a different, more stringent cell strain for expression. Adding 1% glucose to the bacterial culture medium during expression can also help.

Find additional tips, troubleshooting help, and resources within our Protein Expression Support Center.

I'm getting low protein yield from my bacterial expression system. What can I do to improve this?

- Inoculate from fresh bacterial cultures, since higher protein yields are generally obtained from a fresh bacterial colony.

- Check the codon usage in the recombinant protein sequence for infrequently used codons. Replacing the rare codons with more commonly used codons can significantly increase expression levels. For example, the arginine codons AGG and AGA are used infrequently by E. coli, so the level of tRNAs for these codons is low.

- Add protease inhibitors, such as PMSF, to buffers during protein purification. Use freshly made PMSF, since PMSF loses effectiveness within 30 min of dilution into an aqueous solution.

- If you are using ampicillin for selection in your expression experiments, you may be experiencing plasmid instability due to the absence of selective conditions. This occurs as the ampicillin is destroyed by β-lactamase or hydrolyzed under the acidic media conditions generated by bacterial metabolism. You may want to substitute carbenicillin for ampicillin in your transformation and expression experiments.

- The recombinant protein may be toxic to bacterial cells. Try a tighter regulation system for competent cell expression such as BL21-AI. You may also consider trying a different expression system such as the pBAD system.

Find additional tips, troubleshooting help, and resources within our Protein Expression Support Center.

My cells are growing very slowly, and I'm not getting any protein expression from my baterial expression system. What can I do to fix this?

This typically occurs when your gene of interest is toxic. Try using a tighter regulation system, such as BL21 (DE3) (pLysS) or BL21 (DE3) (pLysE), or BL21(AI).

Find additional tips, troubleshooting help, and resources within our Protein Expression Support Center.

Citations & References (1)

Citations & References
Abstract
A novel hematopoietic granulin induces proliferation of goldfish (Carassius auratus L.) macrophages.
Authors:Hanington PC, Barreda DR, Belosevic M,
Journal:J Biol Chem
PubMed ID:16473876
'Granulins are a group of highly conserved growth factors that have been described from a variety of organisms spanning the metazoa. In this study, goldfish granulin was one of the most commonly identified transcripts in the differential cross-screening of macrophage cDNA libraries and was preferentially expressed in proliferating macrophages. Unlike ... More